205 related articles for article (PubMed ID: 17321748)
1. Effects of prolonged angiotensin-converting enzyme inhibitor treatment on amyloid beta-protein metabolism in mouse models of Alzheimer disease.
Hemming ML; Selkoe DJ; Farris W
Neurobiol Dis; 2007 Apr; 26(1):273-81. PubMed ID: 17321748
[TBL] [Abstract][Full Text] [Related]
2. Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor.
Hemming ML; Selkoe DJ
J Biol Chem; 2005 Nov; 280(45):37644-50. PubMed ID: 16154999
[TBL] [Abstract][Full Text] [Related]
3. Conversion of Aβ43 to Aβ40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme.
Liu S; Liu J; Miura Y; Tanabe C; Maeda T; Terayama Y; Turner AJ; Zou K; Komano H
J Neurosci Res; 2014 Sep; 92(9):1178-86. PubMed ID: 24823497
[TBL] [Abstract][Full Text] [Related]
4. ACE inhibition with captopril retards the development of signs of neurodegeneration in an animal model of Alzheimer's disease.
AbdAlla S; Langer A; Fu X; Quitterer U
Int J Mol Sci; 2013 Aug; 14(8):16917-42. PubMed ID: 23959119
[TBL] [Abstract][Full Text] [Related]
5. Reducing amyloid plaque burden via ex vivo gene delivery of an Abeta-degrading protease: a novel therapeutic approach to Alzheimer disease.
Hemming ML; Patterson M; Reske-Nielsen C; Lin L; Isacson O; Selkoe DJ
PLoS Med; 2007 Aug; 4(8):e262. PubMed ID: 17760499
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-converting enzyme overexpression in myelomonocytes prevents Alzheimer's-like cognitive decline.
Bernstein KE; Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Lopes DH; Shah KH; Bernstein EA; Fuchs DT; Yu JJ; Pham M; Black KL; Shen XZ; Fuchs S; Koronyo-Hamaoui M
J Clin Invest; 2014 Mar; 124(3):1000-12. PubMed ID: 24487585
[TBL] [Abstract][Full Text] [Related]
7. Aβ43 is the earliest-depositing Aβ species in APP transgenic mouse brain and is converted to Aβ41 by two active domains of ACE.
Zou K; Liu J; Watanabe A; Hiraga S; Liu S; Tanabe C; Maeda T; Terayama Y; Takahashi S; Michikawa M; Komano H
Am J Pathol; 2013 Jun; 182(6):2322-31. PubMed ID: 23562443
[TBL] [Abstract][Full Text] [Related]
8. Peripherally derived angiotensin converting enzyme-enhanced macrophages alleviate Alzheimer-related disease.
Koronyo-Hamaoui M; Sheyn J; Hayden EY; Li S; Fuchs DT; Regis GC; Lopes DHJ; Black KL; Bernstein KE; Teplow DB; Fuchs S; Koronyo Y; Rentsendorj A
Brain; 2020 Jan; 143(1):336-358. PubMed ID: 31794021
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition.
Zou K; Yamaguchi H; Akatsu H; Sakamoto T; Ko M; Mizoguchi K; Gong JS; Yu W; Yamamoto T; Kosaka K; Yanagisawa K; Michikawa M
J Neurosci; 2007 Aug; 27(32):8628-35. PubMed ID: 17687040
[TBL] [Abstract][Full Text] [Related]
10. Perindopril, a centrally active angiotensin-converting enzyme inhibitor, prevents cognitive impairment in mouse models of Alzheimer's disease.
Dong YF; Kataoka K; Tokutomi Y; Nako H; Nakamura T; Toyama K; Sueta D; Koibuchi N; Yamamoto E; Ogawa H; Kim-Mitsuyama S
FASEB J; 2011 Sep; 25(9):2911-20. PubMed ID: 21593435
[TBL] [Abstract][Full Text] [Related]
11. Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme.
Eckman EA; Adams SK; Troendle FJ; Stodola BA; Kahn MA; Fauq AH; Xiao HD; Bernstein KE; Eckman CB
J Biol Chem; 2006 Oct; 281(41):30471-8. PubMed ID: 16912050
[TBL] [Abstract][Full Text] [Related]
12. [Angiotensin converting enzyme and Alzheimer's disease].
Kugaevskaia EV
Biomed Khim; 2013; 59(1):5-24. PubMed ID: 23650720
[TBL] [Abstract][Full Text] [Related]
13. A clinical dose of angiotensin-converting enzyme (ACE) inhibitor and heterozygous ACE deletion exacerbate Alzheimer's disease pathology in mice.
Liu S; Ando F; Fujita Y; Liu J; Maeda T; Shen X; Kikuchi K; Matsumoto A; Yokomori M; Tanabe-Fujimura C; Shimokata H; Michikawa M; Komano H; Zou K
J Biol Chem; 2019 Jun; 294(25):9760-9770. PubMed ID: 31072831
[TBL] [Abstract][Full Text] [Related]
14. Plaque-associated overexpression of insulin-degrading enzyme in the cerebral cortex of aged transgenic tg2576 mice with Alzheimer pathology.
Leal MC; Dorfman VB; Gamba AF; Frangione B; Wisniewski T; Castaño EM; Sigurdsson EM; Morelli L
J Neuropathol Exp Neurol; 2006 Oct; 65(10):976-87. PubMed ID: 17021402
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin Converting Enzyme Inhibitors Ameliorate Brain Inflammation Associated with Microglial Activation: Possible Implications for Alzheimer's Disease.
Torika N; Asraf K; Roasso E; Danon A; Fleisher-Berkovich S
J Neuroimmune Pharmacol; 2016 Dec; 11(4):774-785. PubMed ID: 27562846
[TBL] [Abstract][Full Text] [Related]
16. Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex.
Ashby EL; Miners JS; Kehoe PG; Love S
J Alzheimers Dis; 2016; 50(4):1191-203. PubMed ID: 26836178
[TBL] [Abstract][Full Text] [Related]
17. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β.
Tayler H; Fraser T; Miners JS; Kehoe PG; Love S
J Alzheimers Dis; 2010; 22(4):1363-73. PubMed ID: 20930272
[TBL] [Abstract][Full Text] [Related]
18. Impacts of aging and amyloid-β deposition on plasminogen activators and plasminogen activator inhibitor-1 in the Tg2576 mouse model of Alzheimer's disease.
Bi Oh S; Suh N; Kim I; Lee JY
Brain Res; 2015 Feb; 1597():159-67. PubMed ID: 25454795
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme as a potential target for treatment of Alzheimer's disease: inhibition or activation?
Zou K; Michikawa M
Rev Neurosci; 2008; 19(4-5):203-12. PubMed ID: 19145983
[TBL] [Abstract][Full Text] [Related]
20. Neprilysin deficiency alters the neuropathological and behavioral phenotype in the 5XFAD mouse model of Alzheimer's disease.
Hüttenrauch M; Baches S; Gerth J; Bayer TA; Weggen S; Wirths O
J Alzheimers Dis; 2015; 44(4):1291-302. PubMed ID: 25408216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]